免疫组织化学市场规模、份额、成长分析（按产品、应用、最终用户、地区）- 2025 年至 2032 年产业预测

2023 年全球免疫组织化学市场规模价值 32.4 亿美元，预计将从 2024 年的 37.1 亿美元成长到 2032 年的 110.5 亿美元，预测期内（2025-2032 年）的复合年增长率为 14.6%。

由于慢性病盛行率的上升和对创新诊断技术的大量投资，全球免疫组织化学市场预计将显着成长。免疫组织化学在药物发现和开发中的应用日益广泛，为该领域的供应商创造了更多的商机。此外，伴随诊断的日益普及预计将随着诊断技术的进步而产生新的商机，从而刺激需求。然而，熟练专业人员短缺、设备成本高以及误报风险等挑战可能会阻碍市场成长。然而，对早期诊断的迫切需求和对先进诊断选择的日益增长的认识预计将为免疫组织化学提供者创造有利条件，为持续的市场扩张铺平道路。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管格局

免疫组织化学市场规模：依产品及复合年增长率（2025-2032）

• 市场概览
• 抗体
  • 一抗
  • 二抗
• 试剂
  • 阻断试剂
  • 呈色受质
  • 稳定剂
  • 缓衝
  • 检测试剂套件
• 装置
  • 玻片染色系统
  • 组织微阵列
  • 自动 IHC 装置
  • 手动染色系统
• 软体
  • 影像分析软体
  • 工作流程管理工具

免疫组织化学市场规模：依应用与复合年增长率（2025-2032）

• 市场概览
• 诊断
• 调查
• 法医学应用

免疫组织化学市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概览
• 医院和诊断实验室
• 学术研究所
• 製药和生物技术公司
• 合约研究组织（CRO）
• 法医学研究所

免疫组织化学市场规模：按地区及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• F. Hoffmann-La Roche Ltd-Switzerland
• Agilent Technologies, Inc.-USA
• Thermo Fisher Scientific Inc.-USA
• Merck KGaA-Germany
• Abcam PLC-UK
• Bio-Rad Laboratories, Inc.-USA
• PerkinElmer, Inc.-USA
• Cell Signaling Technology, Inc.-USA
• Bio SB-USA
• Danaher Corporation-USA
• Takara Bio Inc.-Japan
• Leica Biosystems（Danaher Corporation）-Germany
• Sakura Finetek USA, Inc.-USA
• Biocare Medical, LLC-USA
• Biogenex Laboratories-USA
• Miltenyi Biotec-Germany
• Enzo Life Sciences, Inc.-USA
• Diagnostic Biosystems-USA
• Bio-Techne Corporation-USA

结论和建议

Global Immunohistochemistry Market size was valued at USD 3.24 billion in 2023 and is poised to grow from USD 3.71 billion in 2024 to USD 11.05 billion by 2032, growing at a CAGR of 14.6% during the forecast period (2025-2032).

The global immunohistochemistry market is poised for significant growth, driven by the rising prevalence of chronic diseases and substantial investments in innovative diagnostic technologies. Increased utilization of immunohistochemistry in drug discovery and development further enhances business potential for providers in this sector. The growing adoption of companion diagnostics is anticipated to generate additional opportunities, alongside advancements in diagnostic technologies that will fuel demand. However, challenges such as a shortage of skilled professionals, high equipment costs, and the risk of false positives may impede market growth. Nevertheless, the urgent need for early diagnosis and heightened awareness of advanced diagnostic options are expected to create favorable conditions for immunohistochemistry providers, paving the way for sustained market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Immunohistochemistry market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Immunohistochemistry Market Segments Analysis

Global Immunohistochemistry Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Antibodies, Reagents, Equipment and Software. Based on Application, the market is segmented into Diagnostics, Research and Forensic Applications. Based on End User, the market is segmented into Hospitals & Diagnostic Laboratories, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs) and Forensic Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Immunohistochemistry Market

The global immunohistochemistry market is significantly influenced by the rising incidence of chronic diseases, which underscores the essential role of immunohistochemistry in diagnostics. As the prevalence of these diseases continues to escalate globally, there is a corresponding increase in the demand for immunohistochemistry products and technologies. This growing need for accurate and efficient diagnostic tools to identify and monitor chronic conditions is poised to propel the market forward. Consequently, the increasing focus on improving diagnostic capabilities and patient outcomes through advanced immunohistochemistry solutions is anticipated to further drive market growth in the coming years.

Restraints in the Global Immunohistochemistry Market

The global immunohistochemistry market faces significant restraints due to the high costs associated with its products and technologies, which often involve sophisticated methodologies and considerable investment in research and development. These elevated expenses can hinder adoption among institutions with constrained budgets, ultimately impeding market growth. As a result, facilities with limited financial resources may be unable to integrate these advanced tools into their operations, restricting overall access to immunohistochemistry technologies. Consequently, the financial burden poses a challenge, preventing many healthcare and research establishments from fully benefiting from the advancements available in the immunohistochemistry sector.

Market Trends of the Global Immunohistochemistry Market

The Global Immunohistochemistry market is experiencing a transformative trend towards automation, driven by advancements in technology and the increasing demand for efficient diagnostic solutions. Automated immunohistochemistry systems are anticipated to enhance precision and reduce labor costs, presenting lucrative opportunities for market players. The integration of artificial intelligence into these systems is poised to revolutionize workflows, enabling faster and more accurate staining processes. As laboratories seek to optimize their operations amidst growing workloads, the adoption of automated solutions will not only streamline procedures but also elevate diagnostic capabilities, thereby positioning themselves favorably in an increasingly competitive healthcare landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape

Global Immunohistochemistry Market Size by Product & CAGR (2025-2032)

• Market Overview
• Antibodies
  • Primary Antibodies
  • Secondary Antibodies
• Reagents
  • Blocking Reagents
  • Chromogenic Substrates
  • Fixatives
  • Buffers
  • Detection Kits
• Equipment
  • Slide Staining Systems
  • Tissue Microarrays
  • Automated IHC Instruments
  • Manual Staining Systems
• Software
  • Image Analysis Software
  • Workflow Management Tools

Global Immunohistochemistry Market Size by Application & CAGR (2025-2032)

• Market Overview
• Diagnostics
• Research
• Forensic Applications

Global Immunohistochemistry Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals & Diagnostic Laboratories
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations (CROs)
• Forensic Laboratories

Global Immunohistochemistry Market Size & CAGR (2025-2032)

• North America (Product, Application, End User)
  • US
  • Canada
• Europe (Product, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• F. Hoffmann-La Roche Ltd - Switzerland
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam PLC - UK
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio SB - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. - Japan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Leica Biosystems (Danaher Corporation) - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sakura Finetek USA, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocare Medical, LLC - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogenex Laboratories - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enzo Life Sciences, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diagnostic Biosystems - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations